Latest filing published 05 Mar 2025 for Atara Biotherapeutics, Inc., €7,115.
Filing timeline
BuySaleInsider track record
Jill Henrich: trading record in brief
All filings by Jill Henrich on record concern Atara Biotherapeutics, Inc. Between 16 August 2023 and 3 March 2025, the trades on record add up to 10 filings.
On the market, this insider has only sold: 9 sales, €47k in total. Other entries cover 1 share grant. In 2025 alone, the filings show no purchases and 1 sale.
The latest filing, published on 5 March 2025, reports an open-market sale of €7,115 in Atara Biotherapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jill Henrich
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,059 shares@ US$6.99715.4% of flowCommon StockSEC:0000905148-25-000863:0
- 1,000 shares@ US$11.19823.0% of flowCommon StockSEC:0000905148-24-003243:0
- 831 shares@ US$6.62910.9% of flowCommon StockSEC:0000905148-24-002302:0
- 132 shares@ US$6.6311.7% of flowCommon StockSEC:0000905148-24-002302:1
- 25,750 shares@ US$0.61731.7% of flowCommon StockSEC:0000905148-24-001557:0
- 3,879 shares@ US$0.725.6% of flowCommon StockSEC:0000905148-24-000907:0
- 450,000 shares0Common StockSEC:0000905148-24-000111:0
- 3,267 shares@ US$0.3892.5% of flowCommon StockSEC:0000905148-23-001508:0
- 2,788 shares@ US$1.6539.2% of flowCommon StockSEC:0001140361-23-040559:0
9 of 9 declarations
